Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Clearside Biomedi (NQ: CLSD ) 1.170 +0.020 (+1.74%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Clearside Biomedi < Previous 1 2 3 4 5 Next > What 6 Analyst Ratings Have To Say About Clearside Biomedical April 19, 2023 Via Benzinga Where Clearside Biomedical Stands With Analysts April 19, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 04, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session March 17, 2023 Via Benzinga What 5 Analyst Ratings Have To Say About Clearside Biomedical March 10, 2023 Via Benzinga United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday March 10, 2023 Piper Sandler raised the price target for Riskified Ltd. (NYSE: RSKD) from $6 to $8. Piper Sandler analyst Brent Bracelin upgraded the stock from Neutral to Overweight. Riskified shares rose 2.4% to... Via Benzinga A Preview Of Clearside Biomedical's Earnings March 08, 2023 Via Benzinga Analyst Expectations for Clearside Biomedical's Future February 03, 2023 Via Benzinga Analyst Bumps Up Clearside Biomedical Target Price After Encouraging Trial Data November 10, 2022 Via Benzinga Clearside Biomedical Touts Encouraging Durable Data From Investigational Candidate For Vision Disorder February 02, 2023 Clearside Biomedical Inc (NASDAQ: CLSD) announced results from the Extension Study of its OASIS Phase 1/2a trial of CLS-AX (axitinib) administered by suprachoroidal injection via SCS Microinjector in... Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 31, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 17, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session January 09, 2023 Via Benzinga AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials November 14, 2022 Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign. Via Benzinga Clearside Biomedical: Q1 Earnings Insights May 11, 2022 Clearside Biomedical (NASDAQ:CLSD) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022 November 10, 2022 Upgrades Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 02, 2022 Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 27, 2022 Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million. Via Benzinga Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful August 09, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Recap: Clearside Biomedical Q2 Earnings August 09, 2022 Clearside Biomedical (NASDAQ:CLSD) reported its Q2 earnings results on Tuesday, August 9, 2022. Here's what investors need to know about the announcement. Earnings Clearside Biomedical reported... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session August 08, 2022 Via Benzinga Recap Of Tuesday's Biotech Catalysts - End of The Day Summary July 26, 2022 Via Benzinga Clearside Biomedical Sees Initial-Stage Chronic Eye Disorder Study Results In Q4 2022 July 26, 2022 Clearside Biomedical (NASDAQ: CLSD) has completed dosing in Cohorts 3 and 4 of OASIS study of its lead drug CLS-AX (axitinib injectable suspension) in patients with neovascular age-related macular... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session July 06, 2022 Gainers Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 27, 2022 It's time to dive into the world of early morning trading yet again with the biggest pre-market stock movers for Wednesday! Via InvestorPlace 20 Stocks Moving in Wednesday's Pre-Market Session April 27, 2022 Gainers Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 100.9% to $2.13 in pre-market trading after jumping over 16% on Tuesday. Cosmos Holdings recently posted FY21 adjusted net... Via Benzinga 30 Stocks Moving in Tuesday's Pre-Market Session March 22, 2022 Gainers Smart for Life, Inc. (NASDAQ: SMFL) rose 75.3% to $1.63 in pre-market trading. Smart For Life recently said it is launching various products under the Doctors Scientific... Via Benzinga 68 Biggest Movers From Yesterday March 16, 2022 Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie... Via Benzinga 38 Stocks Moving In Tuesday's Mid-Day Session March 15, 2022 Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session March 14, 2022 Gainers Erytech Pharma (NASDAQ:ERYP) stock rose 18.7% to $1.65 during Monday's pre-market session. The market value of their outstanding shares is at $51.1 million.... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.